Vasospasmolytic therapy in patients with SSC

Adv Exp Med Biol. 1999:455:305-7. doi: 10.1007/978-1-4615-4857-7_45.

Authors

M Jünger¹, A Schlez, T Klyscz, A Steins, M Hahn

Affiliation

¹ Department of Dermatology, University Hospital of Tübingen, Germany.

PMID: 10599360
DOI: 10.1007/978-1-4615-4857-7_45

No abstract available

MeSH terms

Alprostadil / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Cold Temperature
Humans
Iloprost / therapeutic use
Microcirculation / drug effects
Microscopic Angioscopy
Outcome Assessment, Health Care
Raynaud Disease / drug therapy*
Raynaud Disease / etiology
Regional Blood Flow / drug effects
Scleroderma, Systemic / complications
Scleroderma, Systemic / drug therapy*
Vasodilator Agents / therapeutic use*

Substances

Angiotensin-Converting Enzyme Inhibitors
Vasodilator Agents
Alprostadil
Iloprost